DEVELOPMENT OF HIGHLY FLUID, CONCENTRATED AND STABLE FLUOROCARBON EMULSIONS FOR DIAGNOSIS AND THERAPY

被引:64
作者
RIESS, JG
DALFORS, JL
HANNA, GK
KLEIN, DH
KRAFFT, MP
PELURA, TJ
SCHUTT, EG
机构
[1] Alliance Pharmaceutical Corp., San Diego
来源
BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY | 1992年 / 20卷 / 2-4期
关键词
D O I
10.3109/10731199209119726
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A challenging aim in developing injectable fluorocarbon emulsions is to combine good flow characteristics (especially at low shear rates) with the high fluorocarbon concentration required for high oxygen delivery or effective contrast in imaging, long shelf life, and biological acceptability. A good balance of these sometimes conflicting objectives has been achieved with 90% w/v concentrated emulsions of various fluorocarbons, including the radiopaque oxygen carrier perfluorooctylbromide (PFOB, perflubron). The sterile emulsions have viscosities of about 20 cPs at a shear rate of 1 sec-1; the viscosity decreases rapidly with fluorocarbon concentration, and at 60% w/v the viscosity is less than that of human blood. The emulsions are suitable for injection as prepared, and are stable unfrozen for over a year.
引用
收藏
页码:839 / 842
页数:4
相关论文
共 6 条
[1]   LIVER, SPLEEN, AND VESSELS - PRELIMINARY CLINICAL-RESULTS OF CT WITH PERFLUOROOCTYLBROMIDE [J].
BRUNETON, JN ;
FALEWEE, MN ;
FRANCOIS, E ;
CAMBON, P ;
PHILIP, C ;
RIESS, JG ;
BALUMAESTRO, C ;
ROGOPOULOS, A .
RADIOLOGY, 1989, 170 (01) :179-183
[2]  
KRAFFT MP, 1991, J PHYS CHEM-US, V95, pR30
[3]  
LONG DC, 1989, BLOOD SUBSTITUTES, P441
[4]  
LONG DM, 1989, BLOOD SUBSTITUTES, P411
[6]   FLUOROCARBON-BASED BLOOD SUBSTITUTES - WHAT PROGRESS [J].
RIESS, JG .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1991, 14 (05) :255-258